Our systems have detected that you are using a computer with an IP address located in the USA.
If you are currently not located in the USA, please click “Continue” in order to access our Website.

Local restrictions - provision of cross-border services

Swissquote Bank Ltd (“Swissquote”) is a bank licensed in Switzerland under the supervision of the Swiss Financial Market Supervisory Authority (FINMA). Swissquote is not authorized as a bank or broker by any US authority (such as the CFTC or SEC) neither is it authorized to disseminate offering and solicitation materials for offshore sales of securities and investment services, to make financial promotion or conduct investment or banking activity in the USA whatsoever.

This website may however contain information about services and products that may be considered by US authorities as an invitation or inducement to engage in investment activity having an effect in the USA.

By clicking “Continue”, you confirm that you have read and understood this legal information and that you access the website on your own initiative and without any solicitation from Swissquote.

Research Market strategy
by Swissquote Analysts
Boeing Co. (BA) is close to reviving a two-year-old deal for its 787 Dreamliner with Emirates Airline, according to people familiar with the matter. The carrier could announce the deal as early as this week, during the Dubai Airshow, they said. A revived deal for the large planes would mark a...
The surprising dovish bias from the Reserve Bank of Australia is weighing on the Aussie as market participants are finally expecting that further monetary policy easing is on its way. Despite the recent change in stance, we still anti...
The Trump administration extended a license Monday allowing rural telecom providers to continue working with Chinese equipment maker Huawei Technologies Co. despite national security-related restrictions imposed six months ago. The Commerce Department has added 90 days to the duration of a...
The move looks surprising at first sight, as market participants would expect upcoming US – China phase one trade deal signature along with a partial tariffs rollback to ease tensions between both nations, a trend that should ultimate...
Fibrosis, or scarring in the body's organs, is becoming an increasingly hot market as drugmakers make headway in stopping its progression. Roche is buying Promedior for $1.39B in cash and milestones to secure a drug that could treat the lung disease idiopathic pulmonary fibrosis, or IPF, and...
The british pound appears set to recover from last week as market participants seem convinced that the fact that Jeremy Corbyn’s Labor party “close to zero” chance to win majority in the 12 December 2019 general elections should make ...
Live chat